RESULTS

To evaluate the efficacy and safety of empagliflozin/linagliptin in subjects with type 2 diabetes

Year: 2016

OAI identifier: oai:CiteSeerX.psu:10.1.1.1018.554

Provided by: CiteSeerX

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

http://care.diabetesjournals.o... (external link)

http://citeseerx.ist.psu.edu/v... (external link)